NO964180L - Tropan-2-aldoksimderivater som neurotransmitter-gjenopptaksinhibitorer - Google Patents

Tropan-2-aldoksimderivater som neurotransmitter-gjenopptaksinhibitorer

Info

Publication number
NO964180L
NO964180L NO964180A NO964180A NO964180L NO 964180 L NO964180 L NO 964180L NO 964180 A NO964180 A NO 964180A NO 964180 A NO964180 A NO 964180A NO 964180 L NO964180 L NO 964180L
Authority
NO
Norway
Prior art keywords
pct
reuptake inhibitors
tropan
date oct
neurotransmitter reuptake
Prior art date
Application number
NO964180A
Other languages
English (en)
Other versions
NO964180D0 (no
Inventor
Peter Moldt
Frank Watjen
Jorgen Scheel-Krueger
Original Assignee
Neurosearch As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosearch As filed Critical Neurosearch As
Publication of NO964180D0 publication Critical patent/NO964180D0/no
Publication of NO964180L publication Critical patent/NO964180L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Addiction (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

Den foreliggende oppfinnelse beskriver forbindelser med formel (I), (II), (IH)eller (IV) en hver blanding derav eller et farmasøytisk akseptabelt salt derav: hvori R er hydrogen, alkyl, alkenyl, alkynyl, cykloalkyl, cykloalkylalkyl eller 2-hydroksyetyl; R3 er CH=NOR', hvori R' er hydrogen eller alkenyl, alkynyl, cykloalkyl, cyklalkyalkyl, aryl eller alkyl, hvor alle kan substitueres med COOH, COO-alkyl, COO- cykloalkyl, eller fenyl som kan være substituert en eller flere ganger med substituenter valgt fra gruppen som består av halogen, CF3, CN, alkoksy, cykloalkoksy, alkyl, cykloalkyl, alkenyl, alkynyl, amino, nitro; og R4 er fenyl som kan være substituert en eller flere ganger med substituenter valgt fra grupper som består av halogen, CF3, CN, alkoksy, cykloalkoksy, alkyl, cykloalkyl, alkenyl, alkynyl, amino, nitro, heteroaryl og aryl; 3,4- metylendioksyfenyl; benzyl som kan være substituert en eller flere ganger med substituenter valgt fra gruppen som består av halogen, CF3, CN, alkoksy, cykloalkoksy, alkyl, cykloalkyl, alkenyl, alkynyl, amino, nitro, heteroaryl og aryl; heteroaryl som kan substitueres en eller flere ganger med substituenter valgt fra gruppen som består av halogen, CF3, CN, alkoksy cykloalkoksy, alkenyl, amino, nitro, heteroaryl og aryl; eller naftyl som kan være substituert en eller flere ganger med substituenter valgt fra gruppen som består av halogen, CF3, CN, alkoksy, cykloalkoksy, alkyl, cykloalkyl, alkenyl, alkynyl, amino, nitro, heteroaryl og aryl. Forbindelsene innehar verdifulle farmasøytiske egenskaper som monoamin- neurotransmitter-, dvs. dopamin, serotonin, noradrenalin, gjenopptaks-inhibitorer.
NO964180A 1994-04-19 1996-10-02 Tropan-2-aldoksimderivater som neurotransmitter-gjenopptaksinhibitorer NO964180L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK44794 1994-04-19
DK133894 1994-11-24
PCT/EP1995/001358 WO1995028401A1 (en) 1994-04-19 1995-04-12 Tropane-2-aldoxine derivatives as neurotransmitter reuptake inhibitors

Publications (2)

Publication Number Publication Date
NO964180D0 NO964180D0 (no) 1996-10-02
NO964180L true NO964180L (no) 1996-12-16

Family

ID=26064021

Family Applications (1)

Application Number Title Priority Date Filing Date
NO964180A NO964180L (no) 1994-04-19 1996-10-02 Tropan-2-aldoksimderivater som neurotransmitter-gjenopptaksinhibitorer

Country Status (25)

Country Link
US (1) US5736556A (no)
EP (1) EP0756596B1 (no)
JP (1) JP2899418B2 (no)
KR (1) KR100210417B1 (no)
CN (1) CN1043763C (no)
AT (1) ATE222587T1 (no)
AU (1) AU690257B2 (no)
BG (1) BG63259B1 (no)
BR (1) BR9507489A (no)
CA (1) CA2187309C (no)
CZ (1) CZ284379B6 (no)
DE (1) DE69527839T2 (no)
DK (1) DK0756596T3 (no)
EE (1) EE03877B1 (no)
FI (1) FI965074A (no)
GE (1) GEP19991749B (no)
HU (1) HU215830B (no)
LV (1) LV11738B (no)
NO (1) NO964180L (no)
NZ (1) NZ284075A (no)
PL (1) PL183025B1 (no)
RU (1) RU2134264C1 (no)
SK (1) SK280875B6 (no)
UA (1) UA49801C2 (no)
WO (1) WO1995028401A1 (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0859777B1 (en) * 1995-10-13 2007-05-23 Neurosearch A/S 8-azabicyclo(3.2.1)oct-2-ene derivatives, their preparation and use
US6241963B1 (en) * 1995-10-19 2001-06-05 The Trustees Of The University Of Pennsylvania Dopamine and serotonin transporter ligands and imaging agents
IL123898A (en) * 1995-11-02 2001-08-08 Neurosearch As The history of compressed tropane, their preparation and the pharmaceutical preparations containing them
US5948933A (en) * 1997-07-11 1999-09-07 Organix, Inc. Tropane analogs and methods for inhibition of monoamine transport
CA2244773C (en) 1996-02-22 2006-01-03 Neurosearch A/S Tropane-derivatives, their preparation and use
US6232326B1 (en) 1998-07-14 2001-05-15 Jodi A. Nelson Treatment for schizophrenia and other dopamine system dysfunctions
US6417177B1 (en) 1999-07-13 2002-07-09 Alpha Research Group, Llc Chloroquine derivatives for the treatment of Parkinson's disease
US20040229908A1 (en) * 1999-07-13 2004-11-18 Jodi Nelson Compositions and methods for the treatment of Parkinson's disease and tardive dyskinesias
US6667314B2 (en) 2000-05-26 2003-12-23 Pfizer, Inc. Tropane derivatives useful in therapy
JP3693957B2 (ja) * 2000-05-26 2005-09-14 ファイザー・インク 療法において有用なトロパン誘導体
US20040106643A1 (en) * 2001-05-23 2004-06-03 Gouliaev Alex Haarh Tropane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
US6610849B2 (en) * 2001-06-28 2003-08-26 Boehringer Ingelheim Pharma Kg Process for the manufacture of tropenol
WO2003045388A1 (en) * 2001-11-30 2003-06-05 Neurosearch A/S Tropane derivatives having dopamine reuptake inhibitor activity for the treatment of ischemic diseases
DE10200943A1 (de) * 2002-01-12 2003-07-24 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Scopinestern
CA2480742A1 (en) * 2002-03-28 2003-12-04 President And Fellows Of Harvard College Tropane compounds
US7309790B2 (en) 2003-10-03 2007-12-18 Pfizer Inc Chemical compounds
JP2007508336A (ja) * 2003-10-16 2007-04-05 ニューロサーチ、アクティーゼルスカブ モノアミン神経伝達物質再取り込みインヒビター及びアセチルコリンエステラーゼインヒビターを含む医薬組成物
CA2554617A1 (en) * 2004-01-22 2005-08-04 Boehringer Ingelheim International Gmbh Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an n-methyl-d-aspartate (nmda) receptors antagonist
NZ547919A (en) * 2004-01-22 2009-12-24 Neurosearch As Compounds for the sustained reduction of body weight
WO2006075976A1 (fr) * 2005-01-14 2006-07-20 Private Enterprise 'slavyanskaya Klinika' Utilisation d'un anesthesique local pour corriger un comportement alimentaire humain, et procede d'utilisation associe
EP1779851A1 (en) 2005-10-31 2007-05-02 Boehringer Ingelheim Pharma GmbH & Co.KG Treatment of diabetes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU672052B2 (en) * 1992-12-23 1996-09-19 Neurosearch A/S Antidepressant and antiparkinsonian compounds
AU671163B2 (en) * 1992-12-23 1996-08-15 Neurosearch A/S Alkyl substituted heterocyclic compounds

Also Published As

Publication number Publication date
CZ284379B6 (cs) 1998-11-11
ATE222587T1 (de) 2002-09-15
EE9600132A (et) 1997-04-15
EP0756596A1 (en) 1997-02-05
DE69527839T2 (de) 2003-01-02
NO964180D0 (no) 1996-10-02
EE03877B1 (et) 2002-10-15
SK128896A3 (en) 1997-04-09
AU690257B2 (en) 1998-04-23
PL183025B1 (pl) 2002-05-31
LV11738B (en) 1997-12-20
BR9507489A (pt) 1997-08-12
FI965074A0 (fi) 1996-12-17
US5736556A (en) 1998-04-07
RU2134264C1 (ru) 1999-08-10
EP0756596B1 (en) 2002-08-21
HU215830B (hu) 2001-05-28
DE69527839D1 (en) 2002-09-26
KR100210417B1 (ko) 1999-07-15
MX9604966A (es) 1998-05-31
GEP19991749B (en) 1999-09-10
BG100883A (en) 1998-03-31
CA2187309A1 (en) 1995-10-26
BG63259B1 (bg) 2001-07-31
UA49801C2 (uk) 2002-10-15
HUT75865A (en) 1997-05-28
DK0756596T3 (da) 2002-12-23
FI965074A (fi) 1996-12-17
WO1995028401A1 (en) 1995-10-26
AU2257595A (en) 1995-11-10
CN1148854A (zh) 1997-04-30
NZ284075A (en) 1998-01-26
CZ298296A3 (en) 1997-06-11
CN1043763C (zh) 1999-06-23
SK280875B6 (sk) 2000-08-14
PL316876A1 (en) 1997-02-17
HU9602707D0 (en) 1996-11-28
JPH09505607A (ja) 1997-06-03
JP2899418B2 (ja) 1999-06-02
CA2187309C (en) 2000-11-21
LV11738A (lv) 1997-04-20

Similar Documents

Publication Publication Date Title
DK0756596T3 (da) Tropan-2-aldoximderivater som neurotransmitter-genoptagelsesinhibitorer
CA2244773A1 (en) Tropane-derivatives, their preparation and use
BR9610960A (pt) Derivados de 8-azabiciclo [3.2.1] oct -2- eno sua preparação e uso
IL110494A0 (en) Perhydroisoindole derivatives, their preparation and pharmaceutical compositions which contain them
IL151172A0 (en) Amine derivatives, their preparation and use as bax modulators
HRP20050213A2 (en) 2,4-substituted indoles and their use as 5-ht6 modulators
DE69313051D1 (de) Ethanolamin-derivate mit sympathomimetischer und anti-pollakiuria wirkung
BR9607841A (pt) Método para a preparação de estéres de anidroeggonina

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application